🇫🇷
France · FR · FR:62036900
NEOSTIGMINE RENAUDIN 5 mg/5 mL, solution injectable
ATC S01EB06
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerLABORATOIRE RENAUDIN
CountryFR (France)
ATC codeS01EB06
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip13340092693958810 ampoule(s) en verre de 5 ml
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "62036900",
"date_amm": "2013-02-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intramusculaire;intraveineuse;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code S01EB06.
- GBNeostigmine 10mg/5ml oral solutionSpecial Order
- GBNeostigmine 15mg tabletsAlliance Healthcare (Distribution) Ltd
- GBNeostigmine 15mg tabletsAlliance Pharmaceuticals Ltd
- GBNeostigmine 15mg tabletsA A H Pharmaceuticals Ltd
- GBNeostigmine 15mg/5ml oral solutionSpecial Order
- GBNeostigmine 2.5mg/1ml solution for injection ampoulesA A H Pharmaceuticals Ltd
- GBNeostigmine 2.5mg/1ml solution for injection ampoulesAlliance Healthcare (Distribution) Ltd
- GBNeostigmine 2.5mg/1ml solution for injection ampouleshameln pharma Ltd
Access this data programmatically
Query NEOSTIGMINE RENAUDIN 5 mg/5 mL, solution injectable and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.